Preterm Birth and PROM (Premature rupture of membranes) is the rupture of fetal membranes that occurs before 37 weeks’ gestation. This may be caused by natural weakening of the membrane or from the forces of the contraction or due to an infection in the uterus.
The Preterm Birth and Prom Testing Market is anticipated to grow in the forecast, owing to the factors such as rising number of preterm births, increasing average woman being pregnant with diseases like diabetes and high blood pressure, growing demand for point-of-care testing devices and rise in demand for cost effective diagnostic tests.
Get PDF sample copy: https://www.theinsightpartners.com/sample/TIPRE00005197/
The global Preterm Birth and Prom Testing market is segmented on the basis of Test Type and End User. Based on Test type the market is segmented into Preterm Birth Test and PROM tests. Preterm Birth tests is further sub segmented into Pelvic Exam, Ultrasound, Uterine Monitoring, Biomarkers. PROM test is further sub segmented into Nitrazine Test, Ferning Test, Pooling, Ultrasound, Fetal Fibronectin Test, Biomarkers and Others. Based on End User the market is segmented into Hospitals, Diagnostic Laboratories.
– Hologic, Inc
– Medix Biochemica
– Abbott Laboratories
– Clinical Innovations, LLC
– Sera Prognostics, Inc
– The Cooper Companies, Inc
– NX Prenatal, Inc
– IQ Products
Contact Us: Call: +1-646-491-9876 Email: [email protected] Web: https://www.theinsightpartners.com/
, Research Newswire, English